Fusion Finance swings to ₹86 Cr profit YoY as credit costs halve; NPM hits 17.8%
revenue +16.8% · margins expanding
₹485.61 Cr
+16.8% YoY
₹86.48 Cr
17.81%
+22.9pp YoY
₹5.35
Fusion Finance's standalone Q2 FY27 (quarter ended September 30, 2026) PAT came in at ₹86.48 Cr, reversing a ₹22.14 Cr loss in Q2 FY26 and up 38.6% sequentially from ₹62.41 Cr — the company's own release frames this as a 39% QoQ PAT rise. Because the year-ago base was a loss, the headline comparison is a genuine turnaround rather than a growth rate; on an absolute basis the swing is ₹108.6 Cr. Revenue from operations grew a more modest 16.8% YoY (6.0% QoQ) to ₹485.61 Cr, confirming the bottom-line move is a margin story, not a volume story: net profit margin expanded to 17.81% from -5.12% a year ago and 13.62% last quarter, matching the company's own regulatory disclosure exactly.
Q2 FY-2027 vs prior quarters
The driver is squarely credit cost. Impairment on financial instruments fell 65.3% YoY to ₹38.51 Cr from ₹111.15 Cr, as the sector-wide MFI stress that produced last year's loss has eased — Gross Stage III stands at 1.60%, Net Stage III at just 0.11%, with a 93.40% provision coverage ratio, all healthy. That improvement outpaced a 12.1% YoY rise in finance costs (₹150.51 Cr) on a larger borrowing book (₹5,614.95 Cr vs ₹5,210.60 Cr at FY26-end) funding loan growth, and a modest 2.3% YoY rise in employee costs (₹157.73 Cr). On-book loans grew to ₹6,789.56 Cr from ₹6,000.83 Cr at FY26-end (+13.1% half-on-half).
The stock went into the print at ₹133.38, down 23.8% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
Basic EPS of ₹5.35 for the quarter (₹9.22 for H1 FY27) vs a loss per share a year ago; CRAR stood at a comfortable 36.75% and LCR at 148.97%.
AUM target ₹10,000 Cr by March 2027 (currently ₹7,702 Cr). NIM expected to expand 15-20 bps by year-end (range to 25 bps). Credit cost guidance ~2% annualized; OpEx to grow 4-5% initially, with 2-3% reduction targeted through branch rationalization.
— This quarter: met
Against the prior concall's guidance (AUM to ₹10,000 Cr by March 2027, credit cost ~2% annualized, NIM to expand 15-20 bps), the picture is broadly on-track but not fully verifiable from this filing alone: the on-book loan growth is directionally consistent with the AUM push (a web check confirms the ₹10,000 Cr FY27 target remains intact and Q1 FY27 AUM was ₹7,702 Cr), but this filing doesn't disclose a standalone AUM figure or NIM, so neither can be precisely checked here. Annualizing this quarter's impairment charge against the average loan book works out to roughly 2.3-2.4%, still a touch above the ~2% guided level even after nearly halving YoY. No quarter-specific Street consensus for Q2 FY27 PAT could be found (results were only announced today); the only available data point is a broader FY27 full-year consensus of 15-20% PAT growth, a bar this quarter's turnaround comfortably clears in direction if not in like-for-like percentage terms. Alongside the results, the board approved raising the MSME lending ticket-size ceiling from ₹25 lakh to ₹50 lakh, a product-diversification move tying into the growth push. The quarter also saw two senior exits — CSO Priyanka Seth Wadhera and CHRO Pooja Mehta (replaced by Chinmayi Trivedi) — which the numbers show no sign of disrupting operationally.
W1
AUM progress toward the ₹10,000 Cr FY27 target (₹7,702 Cr as of Q1 FY27); confirm the Q2 AUM figure at the concall/investor presentation since this filing discloses only on-book loans (₹6,789.56 Cr).
W2
Credit cost run-rate: this quarter's impairment annualizes to roughly 2.3-2.4% of the loan book, still above management's ~2% guided level even after nearly halving YoY.
W3
NIM trajectory against the guided 15-20 bps (up to 25 bps) expansion by FY27-end — not disclosed in this filing, pending concall confirmation.
Standalone only — company has no subsidiary/associate/JV (note 12), so no consolidated statement exists. Figures are unaudited (Limited Review Report). Tax expense is nil this quarter. No management press release was available separate from the regulatory filing.